[Pulmonary involvement in ulcerative colitis].
Pulmonary involvement has been described to be a very rare complication of inflammatory bowel disease. However, recent studies reported the occurrence of airway diseases (bronchiectasis) or interstitial lung diseases (BOOP) in patients with this disorder. Pulmonary involvement in inflammatory bowel disease is responsive to steroid therapy. Because asymptomatic cases of inflammatory bowel disease with abnormal pulmonary function test has also been reported, the occurrence of pulmonary complications must be evaluated in these patients even in the absence of clinical symptoms.
Taguchi
O
O
Third Department of Internal Medicine, Mie University School of Medicine.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D001987:Bronchiectasis / Q000175:diagnosis / Q000209:etiology*; D003093:Colitis, Ulcerative / Q000150:complications*; D018549:Cryptogenic Organizing Pneumonia / Q000175:diagnosis / Q000209:etiology*; D003937:Diagnosis, Differential; D006801:Humans; D012460:Sulfasalazine / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine